For example, mutant p53, a product of the tumor suppressor gene that is mutated in over 50% of human malignancies, undergoes numerous aggregations in the course of tumor progression, such as metastatic ability or chemoresistance [54]. This evidence concerns the gene TP53 and neoplasm.